Rockwell Automation empowers NKP Pharma achieve regulatory compliance
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
This change is subject to the approval of the shareholders of the company, the Ministry of Corporate Affairs and other statutory and regulatory authorities,
Padmanabhan brings over two decades of extensive experience in FMCG sector
The product will be launched in Q1FY26
The company does not expect this development to have any material impact on the current business operations
The supply of these goods is set to commence within the first quarter of FY26
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
Subscribe To Our Newsletter & Stay Updated